Skip to content

Opening book details…

About this Medicine article

Anti‐IL17A, Ixekizumab, for treatment‐resistant chronic venous leg ulcers: A phase II randomized, double‐blind, placebo‐controlled pilot trial by Cox, C. (author);Fry, K. (author);Sivakumaran, Y. (author);Spelman, L. (author);Khosrotehrani, K. (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Cox, C. (author);Fry, K. (author);Sivakumaran, Y. (author);Spelman, L. (author);Khosrotehrani, K. (author)
Publisher
Wiley
Published
2023
Field
Medicine (Health Sciences)

More by Cox, C. (author);Fry, K. (author);Sivakumaran, Y. (author);Spelman, L. (author);Khosrotehrani, K. (author)

Browse all works by Cox, C. (author);Fry, K. (author);Sivakumaran, Y. (author);Spelman, L. (author);Khosrotehrani, K. (author)